Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
Pro-Dex (PDEX) reported Q4 2026 net sales of $20.4M, up 17% YoY, and net income of $2.9M ($0.87 per share). Full-year 2026 sales rose 16% to $77.5M, with net income at $13.7M ($4.12 per share). Growth was driven by increased revenue from a major customer's next-gen handpiece and the acquisition of APM.
How this was made
The 30-second read
Why it matters
The earnings beat and margin expansion are likely to drive short‑term price appreciation, though cost increases warrant caution.
Market read
First‑report earnings release for a small‑cap med‑tech firm with notable revenue growth and margin improvement.
What to watch
Higher operating expenses and one‑off consulting fees could pressure future margins.
Background
Pro‑Dex, a developer of surgical drivers and shavers, released its FY2026 earnings after acquiring Advanced Precision Machining.
Ticker impact
Pro-Dex reported Q4 and full-year FY2026 results with 16% revenue growth and higher net income.
Potential upside as investors price in higher earnings and margin expansion.
Revenue and profit beat, margin expansion, and acquisition synergies suggest better future cash flow.
Market effects
Positive signal for orthopedic device and medical‑device manufacturing sector.
Boosts sentiment for US small‑cap biotech/med‑tech stocks.
Limited to niche medical‑device market, no broad macro effect.
Counterpoint
Investors may question sustainability of growth given reliance on a single large customer.
Key entities
- CompanyPro‑Dex, Inc.
Medical‑device manufacturer reporting FY2026 results.
- SubsidiaryAdvanced Precision Machining, LLC
Acquired in Q3 2026, contributes to revenue and margin.
